Anuh Pharma Ltd. benchmarking: Perfomance to industry peers

Financial

	Anuh Pharma	Fredun Pharma	Sakar Healthcare
Operational Metrics
Pharmaceuticals
R&D as a % of Total Sales	0.0	n/a	n/a
Financials
5 yr Average ROE	15.87 %	11.84 %	8.14 %
5yr average Equity Multiplier	1.62	2.85	1.76
5yr Average Asset Turnover Ratio	1.35	1.08	0.45
5yr Avg Net Profit Margin	7.23 %	3.9 %	10.03 %
Price to Book	2.21	5.44	2.81
P/E	18.64	43.37	43.7
5yr Avg Cash Conversion Cycle	42.81 Days	175.29 Days	18.72 Days
Inventory Days	50.87 Days	146.68 Days	51.79 Days
Days Receivable	111.12 Days	142.46 Days	53.06 Days
Days Payable	117.6 Days	112.95 Days	115.64 Days
5yr Average Interest Coverage Ratio	48.66	2.62	4.85
5yr Avg ROCE	21.17 %	22.71 %	8.92 %
5yr Avg Operating Profit Margin	10.21 %	9.7 %	24.94 %
5 yr average Debt to Equity	0.02	0.93	0.49
5yr CAGR Net Profit	10.73 %	25.5 %	10.38 %
5yr Average Return on Assets	9.84 %	4.18 %	4.54 %
Shareholdings
Promoter Holding	71.82 %	43.06 %	52.86 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	1.23 %	-7.28 %	-9.24 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Anuh Pharma	Fredun Pharma	Sakar Healthcare
Product Wise Break-Up	Product Wise Break-Up Bulk drug and Chemicals 100.0 0 Loan Licensing 0 Export 0 CDMO 0 Pharmaceuticals 0	Product Wise Break-Up Export 0 Pharmaceutical 100.0 CDMO 0 Bulk drug and Chemicals 0 Loan Licensing 0 Pharmaceuticals 0	Product Wise Break-Up Export 73.0 0 CDMO 22.0 Bulk drug and Chemicals 0 Loan Licensing 5.0 Pharmaceuticals 0
Location Wise Break-Up	Location Wise Break-Up India 45.02 Rest of the World 0 International 0 Domestic 0 Others 54.98	Location Wise Break-Up India 83.13 Rest of the World 16.86 Domestic 0 International 0 Others 0.01	Location Wise Break-Up India 0 Rest of the World 0 Domestic 44.52 International 55.48
Brand Wise Break-Up	Brand Wise Break-Up Erythromycin 33.38 Cortico Steroids 15.41 Higher Macrolides 14.5 Sulphadoxine 13.6 Pyrazinamide 5.74 Chloramhenicol 4.98 Gliclazide 4.23 Ambroxol HCL 3.02 Others 5.14	-	-